INTERWEST PARTNERS X LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2023-02-10 1:00 pm Sale |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 1,714,540 3.800% |
-1,535,004![]() (-47.24%) |
Filing |
2022-02-14 06:51 am Sale |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 3,249,544 7.200% |
-3,220,367![]() (-49.77%) |
Filing |
2021-02-12 06:07 am Purchase |
2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP |
INTERWEST PARTNERS X LP | 6,469,911 14.500% |
6,469,911![]() (New Position) |
Filing |